300583.SZ
Shandong Sito Bio-technology Co., Ltd.
SZSE · Healthcare · C 制造业 · CN
CNY 12.72
−1.32%Margins
Gross margin
18.6%
EBITDA margin
8.3%
EBIT margin
-3.8%
Net margin
-3.9%
FCF margin
9.6%
-2.4%
Return on equity
-1.4%
Return on assets
-1.7%
Return on invested capital
0.37x
Asset turnover
CNY 199.5M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026